Effects of Cannabidiol on Parkinson’s Disease in a Transgenic Mouse Model by Gut-Brain Metabolic Analysis

Table 2

Grading of CST.

Group	Control (C)	Model (M)	CBD (D)
Before ad.	26.25 ± 1.25	13.13 ± 2.30^Δ	12.50 ± 1.89^Δ
After ad.	26.25 ± 1.57	12.50 ± 2.32	17.50 ± 1.89
Improved individuals (proportion)	1 (12.5%)	2 (25%)	4 (50%)

Δ significant different from group C; significantly different from the same group before the administration (ad.).